Identifying the right treatment dose for patients with hemophilia is critical to avoiding adverse health outcomes and improving quality of life. However, even with current technology, this remains a challenge. To improve, more advanced models are needed to predict plasma factor levels, which requires larger and more diverse data sets. Speaker: Erasmus MC Pediatric Hematologist Prof. Dr. Marjon H. Cnoseen Target Audience: This meet-up is ideal for clinicians, medical researchers, data controllers, policy makers and health system managers.
Watch Meet-Up here: